Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)

被引：0
|
作者：
Guanggai Xia
Hongcheng Wang
Ziliang Song
Qingcai Meng
Xiuyan Huang
Xinyu Huang
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of general surgery
[2] Fudan University Shanghai Cancer Center,Department of Pancreatic Surgery, Pancreatic Cancer Institute
来源：
Journal of Experimental & Clinical Cancer Research | / 36卷
关键词：
Pancreatic cancer; Gemcitabine; Gambogic acid; RRM2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2
    Qianfan Liu
    Chunzhuo Song
    Junjun Li
    Meng Liu
    Liyue FU
    Jiuliang Jiang
    Zhirui Zeng
    Haitao Zhu
    Medical Oncology, 39
  • [22] Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
    Nakahira, Shin
    Nakamori, Shoji
    Tsujie, Masanori
    Takahashi, Yuji
    Okami, Jiro
    Yoshioka, Shinichi
    Yamasaki, Makoto
    Marubashi, Shigeru
    Takemasa, Ichiro
    Miyamoto, Atsushi
    Takeda, Yutaka
    Nagano, Hiroaki
    Dono, Keizo
    Umeshita, Koji
    Sakon, Masato
    Monden, Morito
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (06) : 1355 - 1363
  • [23] Tranilast strongly sensitizes pancreatic cancer cells to gemcitabine via decreasing protein expression of ribonucleotide reductase 1
    Mitsuno, Mayumi
    Kitajima, Yoshihiko
    Ohtaka, Kazuma
    Kai, Keita
    Hashiguchi, Kazuyoshi
    Nakamura, Jun
    Hiraki, Masatsugu
    Noshiro, Hirokazu
    Miyazaki, Kohji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (02) : 341 - 349
  • [24] Ribonucleotide Reductase Subunit M2 Levels Affect Resistance to Gemcitabine In Vitro
    Melling, J.
    Shaw, E.
    Dajani, K.
    Lane, B.
    Bauer, A.
    Hoheisel, J.
    Neoptolemos, J.
    Greenhalf, W.
    Ghaneh, P.
    PANCREAS, 2012, 41 (08) : 1384 - 1384
  • [25] DHS (trans−4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)
    Chi-Wei Chen
    Yongming Li
    Shuya Hu
    Wei Zhou
    Yunxiao Meng
    Zongzhu Li
    Yi Zhang
    Jing Sun
    Zhou Bo
    Melvin L. DePamphilis
    Yun Yen
    Zhiyong Han
    Wenge Zhu
    Oncogene, 2019, 38 : 2364 - 2379
  • [26] DHS (trans-4,4′-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2)
    Chen, Chi-Wei
    Li, Yongming
    Hu, Shuya
    Zhou, Wei
    Meng, Yunxiao
    Li, Zongzhu
    Zhang, Yi
    Sun, Jing
    Bob, Zhou
    DePamphilis, Melvin L.
    Yen, Yun
    Han, Zhiyong
    Zhu, Wenge
    ONCOGENE, 2019, 38 (13) : 2364 - 2379
  • [27] SNPS IN RIBONUCLEOTIDE REDUCTASE GENES RRM1 AND RRM2 ARE ASSOCIATED WITH MRNA EXPRESSION AND RESPONSE TO NUCLEOSIDE ANALOGS-BASED CHEMOTHERAPY
    Mitra, A. K.
    Ghosh, T. Mitra
    Feldberg, T. J.
    Pounds, S.
    Cao, X.
    Lamba, J. K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S63 - S63
  • [28] ARID1A promotes chemosensitivity to gemcitabine in pancreatic cancer through epigenetic silencing of RRM2
    Li, Wenyi
    Chen, Qiwei
    Gao, Weiwei
    Zeng, Hui
    PHARMAZIE, 2022, 77 (7-9): : 224 - 229
  • [29] Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
    Mark S. Duxbury
    Hiromichi Ito
    Michael J. Zinner
    Stanley W. Ashley
    Edward E. Whang
    Oncogene, 2023, 42 : 1157 - 1157
  • [30] RETRACTED ARTICLE: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine
    Mark S Duxbury
    Hiromichi Ito
    Michael J Zinner
    Stanley W Ashley
    Edward E Whang
    Oncogene, 2004, 23 : 1539 - 1548
12345